Cross-regulation of Toll-like receptor (TLR) responses by cytokines is essential for effective host defense, avoidance of toxicity and homeostasis, but the underlying mechanisms are not well understood. Our comprehensive epigenomics approach to the analysis of human macrophages showed that the proinflammatory cytokines TNF and type I interferons induced transcriptional cascades that altered chromatin states to broadly reprogram responses induced by TLR4. TNF tolerized genes encoding inflammatory molecules to prevent toxicity while preserving the induction of genes encoding antiviral and metabolic molecules. Type I interferons potentiated the inflammatory function of TNF by priming chromatin to prevent the silencing of target genes of the transcription factor NF-κB that encode inflammatory molecules. The priming of chromatin enabled robust transcriptional responses to weak upstream signals. Similar chromatin regulation occurred in human diseases. Our findings reveal that signaling crosstalk between interferons and TNF is integrated at the level of chromatin to reprogram inflammatory responses, and identify previously unknown functions and mechanisms of action of these cytokines.
The cytokine TNF is important in innate immunity, inflammation and host defense against microbial pathogens 1 . TNF is also a key pathogenic cytokine and driver of chronic inflammation in various autoimmune and inflammatory diseases 2 . Classical inflammatory activation of cells by TNF is mediated by canonical signaling via the transcription factor (TF) NF-κB and kinases of the MAPK family that activate well-known genes that encode inflammatory molecules, such as IL1 and IL6. TNF also has potent paradoxical anti-inflammatory functions 3 that limit inflammation-associated toxicity 4 . Perhaps the most potent suppressive mechanism induced by TNF is 'cross-tolerance' 3 , which resembles classical endotoxin tolerance 5 in that various ligands of the TLR family of receptors and inflammatory stimuli are unable to induce the transcription of select genes encoding inflammatory molecules. Much less is known about the induction of cross-tolerance by TNF than about endotoxin tolerance, and little is known about how the tolerizing functions of TNF are over-ridden, such that TNF is able to drive chronic inflammation.
Type I interferons activate the Jak-STAT signaling pathway to induce expression of interferon-stimulated genes (ISGs) that are activated by STAT proteins via binding to the conserved DNA elements ISRE (interferon-stimulated response element) and GAS (inter-feron-γ (IFN-γ)-activated site) 6 . ISGs include those encoding antiviral proteins, chemokines and antigen-presenting molecules; thus, type I interferons can promote antiviral and immune responses and have been linked to autoimmune diseases. However, type I interferons can also have a suppressive role in certain chronic infections and in multiple sclerosis 6 . Distinct interferon functions may be related to context-dependent effects on NF-κB-driven genes encoding inflammatory molecules, as interferons can either suppress cytokines or contribute to increased cytokine production in diseases such as systemic lupus erythematosus (SLE), to increased inflammation when bacterial infection follows viral infection, and to microbiota-mediated priming of cytokine responses [6] [7] [8] [9] . The mechanisms by which type I interferons regulate NF-κB target genes that encode inflammatory molecules, which are not targets of the Jak-STAT signaling pathway, are not known 10, 11 .
Potent inflammatory activators of macrophages, such as TLR ligands, activate signaling via the NF-κB, MAPK-TF AP-1 and TF IRF3 pathways to induce the expression of genes encoding inflammatory cytokines 12 . The ability of signal-responsive TFs to induce transcription is modulated by the chromatin state of the regulatory elements (promoters and enhancers) of the gene [13] [14] [15] [16] [17] . The activation of many TLR-inducible genes, including Il6, Il12b and Ifnb, requires an increase in chromatin accessibility via the deposition of positive histone marks and remodeling of nucleosomes to create nucleosome-free regions at promoters and enhancers [13] [14] [15] . Published work has shown that environmental cues can 'fine-tune' the macrophage enhancer repertoire [18] [19] [20] [21] [22] [23] . The induction of newly formed ('latent') enhancers can explain tissue-specific macrophage gene expression and raises the possibility that the remodeling of enhancers can alter cellular responses to environmental signals. However, analysis of the effects of epigenomic remodeling on cellular responses to secondary inflammatory challenges has been limited. Furthermore, little is known about whether signaling crosstalk occurs in the nucleus at the level of chromatin during an inflammatory TLR-driven response.
It has been reported that TNF induces a state of 'cross-tolerance' in which various TLR ligands are unable to induce transcription of genes encoding the canonical inflammatory NF-κB-dependent cytokines IL-1β, IL-6 and TNF and that protects mice from the lethality of endotoxins in vivo 3 . In the current study we sought to understand TNF-induced cross-tolerance in greater depth and to determine whether macrophages can escape cross-tolerance; abolishing this feedback mechanism could provide an explanation for how TNF can drive sustained unremitting inflammation in a chronic setting. We took a comprehensive and integrated genome-wide approach that included RNA-based next-generation sequencing (RNA-seq), chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) and assay for transposase-accessible chromatin followed by deep sequencing (ATAC-seq) 24 , together with 'digital footprinting' 25 , to investigate the regulation of TLR4 responses by TNF. We discovered that type I interferons effectively abolished TNF-induced cross-tolerance by priming chromatin to enable robust transcriptional responses to weak signals. These findings reveal mechanisms by which cytokine signaling crosstalk is integrated at the epigenomic level and identify a previously unknown function and mechanism of action for type I interferons.
RESULTS

TNF reprograms the TLR4 response in human macrophages
Published work has shown that pretreatment of cells with TNF strongly attenuates the lipopolysaccharide (LPS)-induced signaling and chromatin remodeling that occurs after secondary challenge 3, 5 . To gain insight into gene regulation in TNF-induced tolerance, we performed transcriptomic analysis using RNA-seq. We used an established system in which primary human macrophages are pre-treated for 24 h with TNF before challenge with LPS 3 (Fig. 1a ) and focused our analysis on the 1,574 genes that were strongly induced (over threefold) in response to LPS (data not shown). Clustering of LPSinducible genes by expression pattern revealed twelve clusters that could be assembled into six main classes ( Fig. 1b and Supplementary  Fig. 1a ). Two classes of robustly LPS-inducible genes were minimally induced by LPS (class 1; n = 466 genes) or weakly induced by LPS (class 2; n = 245 genes) in macrophages pretreated with TNF ( Fig. 1b) . According to published nomenclature 5,26 , we called these 'tolerized genes' ('T genes'). Class 1 showed enrichment for gene-ontology (GO) terms related to 'defense response' and 'inflammatory response' (Fig. 1c ) and included many genes encoding pro-inflammatory cytokines ( Fig. 1d ) and NF-κB target genes ( Fig. 1e) . Thus, TNFinduced cross-tolerance was broadly similar to endotoxin tolerance 26, 27 in the transcriptional silencing of NF-κB target genes encoding inflammatory molecules.
LPS effectively and paradoxically induced the expression of various genes in TNF-treated cells (classes 3-6; Fig. 1b and Supplementary  Fig. 1a,b ) despite minimal LPS-induced signaling 3 (also discussed below). In line with published reports on endotoxin tolerance 26, 28 , we called these 'nontolerized genes' ('NT genes'). Class 3 was composed of genes (n = 403) strongly induced by LPS in both naive cells and TNF-treated cells; class 3 NT genes were most clearly regulated in a manner directly opposite to the manner in which T genes were regulated ( Fig. 1b and Supplementary Fig. 1a,b) . In contrast, genes in class 4 (n = 285) and class 5 (n = 82) had substantial expression in TNF-treated cells and were superinduced by secondary LPS challenge ( Fig. 1b and Supplementary Fig. 1a ), which revealed cooperation and even synergy (class 4A; Supplementary Fig. 1a ) between the 'tolerizing' factor TNF and LPS.
In addition to having different expression patterns, the NT gene classes encoded products with distinct functions, as revealed by gene-ontology analysis. Class 3 showed enrichment for GO categories related to cytokine and interferon signaling via the Jak-STAT pathway; class 4 showed enrichment for GO categories related to metabolic pro cesses; and classes 5 and 6 included additional genes encoding molecules involved in important in lipid-metabolic processes ( Fig. 1c,d ; complete list of genes, Supplementary Table 1 ).
The gene classes also differed in TF-binding motifs for which their promoters showed enrichment, relative to the abundance of such motifs in all other annotated promoters. The promoters of class 1 T genes showed the most significant enrichment for binding motifs for NF-κB and the TF NFE2L1; class 3 NT genes showed the most significant enrichment for ISREs (that bind the type I interferon-activated TF ISGF3); and class 4 NT genes showed the most significant enrichment for binding sites for the TF SREBP, which drives the expression of genes encoding molecules involved in cholesterol pathway and lipid metabolism ( Fig. 1e) . Thus, in addition to having different patterns of expression and different functions, the gene classes had distinct mechanisms of regulation. As predicted, various class 3 NT genes were dependent on type I interferon signaling, whereas class 4 NT genes were not ( Supplementary Fig. 1c ).
The gene classes could also be distinguished on the basis of the kinetics of their induction by TNF. Class 1 (T genes) was composed largely of early TNF-induced genes, which peaked at 1-3 h after treatment with TNF and decreased in expression by 24 h ( Supplementary  Fig. 2a) . In contrast, genes in classed 3 and 4 exhibited delayed induction kinetics; unlike the gradual increase in the expression of class 3 genes, class 4 genes exhibited induction only at the late time point (24 h) ( Supplementary Fig. 2a ). We then compared the activity of TNF-induced genes (n = 433 genes; at 1 or 3 h after induction) and LPS-induced genes (n = 1,219 genes; at 3 h after induction) to test the possibility that TNF tolerance affected only TNF-induced genes. Strikingly, TNF tolerized a large fraction of LPS-inducible genes that were not induced by TNF ( Supplementary Fig. 2b ), in support of the idea of cross-tolerance.
Collectively, these results revealed that TNF extensively reprogrammed the LPS response, with TNF-induced 'cross-tolerance' representing one component of 'reprogramming' . The TNF-reprogrammed state seemed to differ from classical endotoxin tolerance by the expression of interferon-and/or cytokine-driven genes (class 3) and genes encoding molecules involved in lipid-metabolic processes (classes 4-6) after LPS challenge.
TNF regulates chromatin and TFs to reprogram LPS responses
TLR4 signaling is almost completely abolished in macrophages pretreated with TNF or endotoxin, and epigenetic mechanisms have been linked to tolerance. Consistent with an epigenetic mechanism, TNF-induced tolerance was sustained for at least 48 h after 'washout' of TNF ( Supplementary Fig. 2c ). As epigenetic regulation has been studied for only a small number of T genes and not for NT genes, we performed genome-wide analysis of nine histone marks using ChIP-seq, and of chromatin accessibility using ATAC-seq, to gain greater insight into the role of chromatin regulation in TNF-induced reprogramming of the TLR4 response. 1 1 0 6 VOLUME 18 NUMBER 10 OCTOBER 2017 nature immunology A r t i c l e s We found that tolerization with TNF attenuated the LPS-induced increase in the positive histone marks H4ac and H3K4me3 (associated with open chromatin and transcription) and increased chromatin accessibility (ATAC-seq reads) ( Fig. 2a ; quantification, Supplementary  Fig. 3a ; gene tracks, Fig. 2b and Supplementary Fig. 3b ). These results were in agreement with a model in which LPS is unable to generate a sufficiently strong signal in endotoxin-tolerized cells to induce the chromatin remodeling that is required for effective induction of transcription 3, 26, 29, 30 . We also found that tolerization attenuated the LPS-induced increase in ubiquitination of the histone H2BK120 (H2Bub) ( Fig. 2a) , a positive mark that serves to increase H3K4me3 and open chromatin and is a prerequisite for H3K4me3 in other systems. This indicated that the inability of LPS to generate signals that lead to H2Bub contributed to the tolerization of these genes.
NT genes in classes 3-6 exhibited distinct chromatin-regulation profiles. Notably, class 3 NT genes, which encode molecules functionally related to interferon and/or cytokine-Jak-STAT signaling, were marked by H2Bub and H4ac after treatment with TNF, which was associated with substantial inducibility of H3K4me3, opening of chromatin, and robust induction of gene expression in response to weak signaling after LPS challenge ( Fig. 2a and Supplementary Fig. 3a ; gene tracks, Fig. 2b and Supplementary Fig. 3b ). This suggested that marking or 'priming' of class 3 NT genes by H2Bub and H4ac enabled chromatin remodeling and transcriptional responses even to weak signals. Genes in classes 4-6 differed from those in classes 1-3 in that H2Bub, H3K4me3 and open chromatin (ATAC-seq read density) in the former group were lower at baseline in naive macrophages and were weakly inducible by LPS ( Fig. 2a and Supplementary Fig. 3a,c) . Instead of being induced by acute stimulation with LPS, these positive marks and opening of chromatin were induced during TNF stimulation ( Fig. 2a,b and Supplementary Fig. 3a,b) , which suggested that their epigenetic profile was 'primed' by TNF. The patterns of regulation were confirmed in additional replicates (Supplementary Fig. 4a ) and by ChIP followed by qPCR and by formaldehyde-assisted isolation of regulatory elements (FAIRE), for select genes in cells from additional donors ( Supplementary Fig. 4b and data not shown). We found exceptions in which histone marks did not correlate with transcriptomic changes (Supplementary Note 1) and used ChIP-seq Distinct epigenetic landscape at different TLR4-induced gene classes. (a) ChIP-seq analysis of H4ac, H3K4me3 and H2Bub (above plots), as well as ATAC-seq analysis (ATAC), of genes in classes 1-6 (left margin; classes and order of genes in each column throughout, as in Fig. 1b ), assessed in conditions of various combinations of pre-treatment for 24 h with TNF before challenge with LPS (as in Fig. 1a ; below plots) and presented as normalized tag density at the promoter (from 2 kb upstream to 2 kb downstream, relative to the transcription start site) (quantification, Supplementary Fig. 3a ). Supplementary Fig. 4a ), three to five experiments with independent donors (biological replicates) with similar results (a,b, ATAC-seq; pooled data, Supplementary Fig. 4a ) or two experiments with different donors (biological replicates) (c). to analyze other less-informative or repressive histone marks ( Supplementary Fig. 3c-e ). The regulation of histone marks and chromatin accessibility at enhancers in TNF-treated cells paralleled that of promoters but was quantitatively less dynamic ( Supplementary Fig. 5a ).
In addition, CpG islands 11 , super-enhancers 31 and latent enhancers 20 did not correlate with patterns of regulation of the various gene classes (Supplementary Fig. 5b-d) . Overall, these data supported a model in which TNF alters chromatin states at TLR4-inducible gene promoters to reprogram the TLR4-induced gene response to silence the expression of NF-κB-dependent genes encoding inflammatory molecules while augmenting the expression of cytokine-induced genes encoding antiviral and metabolic molecules.
To identify candidate TFs that could explain the differential expression and regulation of the distinct gene classes, we identified digital footprints (P < 10 −10 ) 'under' ATAC-seq promoter peaks, then matched those to all known TF motifs (examples of well-delineated TF footprints, Fig. 2c and Supplementary Fig. 4c ). This approach has an advantage over motif enrichment in that it identifies sites that are actually bound by TFs, rather than just motifs that have the potential to bind TFs. Footprinting analysis recovered the binding of the TFs PU.1 and Ets to gene elements, the binding of TF NF-Y and TF SP-1 to core promoter elements 32 , and inducible binding of NF-κB to gene elements ( Fig. 3a) , which supported the validity of this approach. Strikingly, footprinting analysis clearly identified distinguishing 3,000 CCL3  IL8  TRAF1  ICAM1  TNF  TNFAIP8  NFKB1  IL6  IRF8  IL27  CTNNB1  KLF6  CCL20  STAT5A  IL1R1  CXCL9  TNFSF9  IL1A  PTGS2  CXCL3  IRAK2  INHBA  KDM6B  HES1 (c) Expression of transcripts from a subset of class 1 genes (right margin) whose tolerization was reversed by IFN-α treatment, assessed in experimental conditions as in a (above plot (as in b)); results are presented relative to maximum, set as 1. (d) Immunoblot analysis of total IκBα, NF-κB subunit p50 and its precursor p105 (p105-p50), NF-κB subunit cRel, NF-κB subunit p52 and its precursor p100 (p100-p52), and NF-κB subunit RelB, as well as phosphorylated (p-) IKKβ, ERK and STAT1 (phosphorylated at Tyr701), and the kinase p38 (loading control), in primary macrophages cultured for 24 h with no TNF or IFN-α (−) or with TNF (10 ng/ml) with or without IFN-α (25 ng/ml) (above blots), and challenged for 0-60 min (above lanes) with LPS (10 ng/ml). A r t i c l e s features among the promoters in the different gene classes. The most salient class-specific characteristics were inducible occupancy of TF IRF and ISRE sites at the promoters of class 3 NT genes, consistent with regulation by interferons and cytokines, and of AP-1 sites in the promoters of class 4 genes, under conditions in which cells were treated with TNF or with TNF plus LPS (Fig. 3a) . Accordingly, TNF induced sustained expression of AP-1 proteins (Fig. 3b) , and induction of the genes encoding these proteins was sensitive to MAPK inhibitors 26 (data not shown). We noted patterns of expression of members of relevant TF families ( Fig. 3c and Supplementary  Table 1 ; additional detailed description of footprinting results, Supplementary Note 2). Footprinting analysis of enhancers showed inducible binding of TFs to NF-κB, IRF, AP-1 and C/EBP-AP-1 sites ( Supplementary  Fig. 5e ), similar to the inducible binding detected at promoters noted above, which suggested that enhancers were also responsive to TNF and LPS. However, the occupancy of TF-binding sites at enhancers was more similar among the six gene classes than was occupancy of promoters ( Fig. 3a) . In agreement with the footprinting analysis, de novo motif enrichment analysis under enhancer ATAC-seq peaks with the HOMER suite of tools for motif discovery and next-generation sequencing analysis showed similarity among the gene classes (Supplementary Fig. 5f) . Overall, the ChIP-seq and footprinting results provided insight into the distinct regulatory 'logic' of the various gene classes and suggested a role for IRF TFs and ISGF3 (class 3 NT genes) or AP-1 (class 4 NT genes) in opening chromatin and allowing these genes to escape tolerance.
Expression of LPS-induced gene classes in human disease
To address whether our findings reflected the regulation of genes encoding inflammatory molecules in vivo, we assessed expression of the six classes of LPS-inducible genes in human disease states. First, we analyzed gene expression in monocytes collected from patients both during sepsis (and thus exposed to both endotoxins and TNF) and after recovery and then stimulated ex vivo with LPS 28 . Strikingly, genes in classes 1 and 2 exhibited tolerization in vivo that was reversed when patients recovered (Fig. 3d) , which recapitulated the results obtained with our in vitro model. Genes in classes 4-6 also exhibited expression patterns in patients with sepsis similar to those in our system, but genes in class 3 exhibited limited inducibility by LPS ex vivo (Fig. 3d) . This reinforced the proposal that inducibility of genes targeted by interferon was a feature that distinguished TNF-induced reprogramming from endotoxin tolerance. We also found that the expression of genes in two NT gene sets, in class 3 and class 4, was significantly elevated in synovial macrophages from people with rheumatoid arthritis (RA), a condition in which inflammation is driven by TNF ( Fig. 3e,f) .
Overall, these results supported the proposal that the patterns of gene regulation and classes of genes encoding inflammatory molecules we identified in our model system reflected aspects of the regulation of genes encoding inflammatory molecules in vivo in infectious or inflammatory disease states.
Type I interferons abolish TNF-mediated tolerance
Building on published work showing that inhibition of the glycogensynthase kinase GSK3 reverses TNF-induced tolerance and that GSK3 regulates the production of interferon 3,5,33 , we found that reversal of tolerization of the gene encoding the cytokine IL-6 (IL6) via inhibition of GSK3 was mediated by an increased abundance of type I interferons (Supplementary Fig. 4d-g) . We assessed the effect of type I interferons on TNF-induced tolerance genome wide by RNAseq. The addition of exogenous IFN-α together with TNF ( Fig. 4a ) significantly restored LPS inducibility to the majority of class 1 T genes (60.7% (283 of 466 genes); Fig. 4b,c) , which indicated a broad but gene-specific reversal of tolerance. IFN-α affected expression of the six TLR4-induced gene classes differentially, and few genes among the NT genes in classes 4-6 (21-23%) were upregulated by IFN-α ( Fig. 4b) . Notably, type I interferons did not reverse the tolerization of TNF and IL6 by LPS in the classic endotoxin model ( Supplementary  Fig. 4g ). IFN-α increased the LPS-induced expression of genes in class 1 only in TNF-treated cells (Fig. 4b) , in accord with extensive literature showing that class 1 T genes are not canonical ISGs. Thus, crosstalk between interferons and TNF coupled interferon signaling with class 1 NF-κB target genes and prevented their tolerization. We investigated whether IFN-α could augment LPS-induced signaling in tolerized macrophages. As expected 3 , we observed robust LPS-induced degradation of the inhibitory cytoplasmic NF-κB chaperone IκBα and activation of the kinases IKK and ERK in naive macrophages, but this was substantially blunted in TNF-tolerized macrophages (Fig. 4d) . In contrast to its effects on gene expression, IFN-α did not reverse those defects in proximal LPS-induced TLR signaling (Fig. 4d) . IFN-α also did not affect the TNF-induced expression of noncanonical NF-κB proteins suggested to have a role in tolerance 27, 34 (Fig. 4d) . These results indicated that IFN-α strongly affected the transcriptional responses of genes in classes 1 and 2 without substantially altering proximal TLR signaling defects.
The gene-specific effects of IFN-α (Fig. 4b) , together with its ability to enable robust induction of T genes in response to very weak TLR4induced proximal signals in TNF-pretreated cells, suggested that IFN-α exerted its effects in the nucleus at the level of gene regulation. To test this idea, we first confirmed that IFN-α-mediated abolition A r t i c l e s of gene tolerization occurred at the level of transcription, by measuring primary transcripts (Fig. 4e) . Furthermore, ChIP-qPCR showed that IFN-α overcame the TNF-induced block in the recruitment of RNA polymerase II to the tolerized gene IL6 (Fig. 4f) . These results supported the proposal that IFN-α signaling acted in the nucleus to regulate gene expression.
Crosstalk between interferons and TNF primes chromatin at T genes
We reasoned that IFN-α might amplify transcriptional responses of genes in classes 1 and 2 to weak LPS signals in TNF-treated macrophages by remodeling chromatin. That proposal was supported by FAIRE assays showing that IFN-α promoted the opening of chromatin at the IL6 promoter in TNF-treated macrophages (Fig. 5a) . We then used ATAC-seq and ChIP-seq to analyze chromatin accessibility and the positive marks H2Bub and H3K4me3 genome wide. IFN-α did not significantly increase ATAC-seq read counts at the majority of class 1 genes in resting or LPS-stimulated naive cells (P > 0.27; Supplementary  Fig. 6b) . However, the combination of IFN-α and TNF resulted in increased chromatin accessibility at the promoters of class 1 genes, with a further increase after LPS stimulation ( Fig. 5b and Supplementary  Fig. 6b; gene tracks, Fig. 5c and Supplementary Fig. 6d) . A similar signal-responsive but quantitatively less-dynamic pattern was observed at the enhancers of class 1 genes (Supplementary Fig. 6c) .
A similar pattern of an increase in H3K4me3, which marks open chromatin, was observed when IFN-α was added to conditions in which cells were treated with TNF or with TNF plus LPS (Fig. 5b,c and Supplementary Fig. 6b,d) . The breadth of H3K4me3 peaks and extension of this 'promoter mark' into gene bodies, which is associated with increased transcription 35 , was increased by IFN-α in a similar manner (Fig. 5d) . Notably, IFN-α and TNF acted cooperatively to increase the breadth of the H3K4me3 peaks (Fig. 5d) . Finally, H2Bub, a prerequisite for H3K4me3 in other systems, was also increased when IFN-α and TNF were added together (Fig. 5b) . Those results were strikingly different from results obtained in the absence of IFN-α, in which chromatin remained closed ( Fig. 2a  and Supplementary Fig. 6b) . These results showed that the addition of IFN-α together with TNF conditioned or 'primed' chromatin at the promoters of class 1 genes, and that this was able to facilitate transcriptional responses to weak LPS signals. In accord with the marking of open chromatin by H3K4me3, in macrophages treated with IFN-α plus TNF and then stimulated with LPS (the 'IFN-T-L' condition), we observed broad ATAC-seq peaks that extended into gene bodies (Fig. 5c,e) . Thus, the opening of chromatin at class 1 genes was a salient feature of the action of IFN-α in TNF-treated macrophages, and IFN-α and TNF acted together to prevent gene silencing. 
A r t i c l e s
Interferons and TNF act together to recruit TFs to class 1 genes We addressed the possibility that the opening of chromatin at the promoters of class 1 genes under tolerizing conditions required cooperation between TFs induced by IFN-α and those induced by TNF.
De novo motif analysis of TF footprints under ATAC-seq peaks in IFN-T-L conditions revealed that under interferon-stimulated conditions, these promoters newly gained occupancy of IRF sites (Fig. 6a) . The enhancers of class I genes showed enrichment for a similar ISRE site, relative to the abundance of this site in random genomic fragments of the same size (Supplementary Fig. 7a ). Motif analysis of TF footprints in the most 'primed' chromatin, as defined by peaks with high read density of ATAC-seq, H2Bub or H3K4me3, revealed enrichment for NF-κB and IRF motifs, relative to the abundance of these motifs in random genomic fragments of the same size (Fig. 6b) . Most strikingly, peaks with the greatest chromatin accessibility were associated with a composite NF-κB-IRF motif (Fig. 6b) , and several IRFs were induced in IFN-α-treated, tolerized macrophages ( Fig. 6c and Supplementary Fig. 7b ). This suggested that coordinated binding of TNF-induced NF-κB and interferon-induced IRF TFs to the promoters of class I genes contributed to increased chromatin accessibility. That conclusion was supported by ChIP-seq data showing that after treatment with TNF plus IFN-α, a large fraction of IRF1 binding peaks at promoter elements of class 1 genes (ATAC-seq peaks) localized together with peaks for the NF-κB subunit p65 ( Fig. 7a ; gene tracks showing peak alignment, Fig. 7b and Supplementary  Fig. 7c ). Increased co-recruitment of IRF1 and p65 after treatment with TNF plus IFN-α was confirmed for a subset of genes, by ChIP-qPCR ( Fig. 7c and Supplementary Fig. 7d ). Significantly increased colocalization of the binding of IRF1 and p65 was also observed when an independent data set (GEO accession code GSE43036) was used to define IRF1 peaks (P < 0.0001; Supplementary Fig. 7e,f) . Overall, these results supported a model in which TNF-induced NF-κB and IFN-α-induced IRF TFs bound coordinately to promoters of class 1 T genes and acted together to maintain an open and 'primed' chromatin state, which enabled strong transcriptional responses to weak LPS-induced signals (Supplementary Fig. 8 ).
Escape of IL6 transcription from suppression by IL-10
One potential consequence of the 'priming' of chromatin in macrophages treated with TNF plus IFN-α would be a change in the transcriptional requirements for LPS-induced activation of genes. We tested this for IL6, a class 1 gene whose induction by LPS in naive macrophages was dependent on de novo protein synthesis (which is required for increased chromatin accessibility) 11, 30 and was suppressed by the potent anti-inflammatory cytokine IL-10 ( Fig. 7d,e) . In contrast to its expression in naive, LPS-stimulated macrophages, IL6 expression in macrophages treated with TNF plus IFN-α was strongly induced by LPS in the presence of the protein-synthesis inhibitor cycloheximide (Fig. 7d) . IL-10 essentially completely suppressed LPS-induced IL6 expression in naive macrophages, but suppressed it only partially in IFN-α-primed, tolerized macrophages (Fig. 7e) . These results indicated that 'priming' by crosstalk between IFN-α and TNF changed the regulatory 'logic' of gene expression and was able to make genes resistant to suppression by anti-inflammatory stimuli and thereby promoted sustained TNF-driven inflammation.
Chromatin accessibility in monocytes from people with SLE Type I interferons have been proposed to contribute to the pathogenesis of SLE by opposing tolerance induction 36 . We reasoned that monocytes obtained from people with SLE, and thus exposed in vivo to interferons, TNF and TLR ligands, might exhibit an altered epigenomic or chromatin landscape that reflected some of the interferon-mediated regulatory mechanisms we have described in this study. Pearson correlation analysis showed that the chromatin-accessibility profile of monocytes obtained from people with SLE and stimulated with LPS ex vivo was closely correlated with the profile of IFN-α-treated, tolerized cells stimulated with LPS in our system (IFN-T-L conditions) but did not correlate with the profile of LPS-stimulated naive cells or tolerized cells (Fig. 8a) . Analysis of the tracks of individual genes revealed that in monocytes obtained from people with SLE, LPS induced a broad region of chromatin accessibility that extended into the gene bodies (Fig. 8b) , reminiscent of results obtained with IFN-α-treated tolerized cells (IFN-T-L conditions; Fig. 5c,e) . This was in agreement with the broad H3K4me3 peaks in our system (Fig. 5d,) and reported for monocytes from people with SLE 37 .
Given the importance of type I interferons in SLE, we next turned our attention to IFNB1 (which encodes IFN-β). Strikingly, IFN-α led to massive super-induction of IFNB1 by LPS, but only in cells that were also treated with TNF ( Fig. 8c) . Thus, IFNB1 resembled class 1 genes in that its induction required preconditioning by IFN-α and TNF, followed by LPS challenge. LPS challenge of cells treated with IFN-α plus TNF induced a broad region of chromatin accessibility at IFNB1 that extended from the promoter into the gene body, and similar results were obtained for monocytes obtained from donors with SLE and stimulated with LPS, but not for their counterparts obtained from healthy donors (Fig. 8d) . To further compare monocytes from donors with SLE with IFN-α-primed, tolerized monocytes, we performed de novo motif analysis under ATAC seq peaks of LPSchallenged cells. Similar to cells treated to the IFN-T-L condition (Fig. 6a) , monocytes obtained from donors with SLE and stimulated with LPS showed enrichment for IRF motifs in ATAC-seq footprints, relative to the abundance of such motif in random genomic fragments of the same size; this result was probably related to in vivo exposure to type I interferons and was not observed in monocytes from healthy donors stimulated with LPS ( Fig. 8e) . Overall, the results showed similarities between monocytes from donors with SLE and IFN-α-treated, tolerized monocytes in their LPS-induced chromatin accessibility in class 1 genes, which suggests that our model system mimics aspects of chromatin regulation in an interferon-mediated disease in vivo.
DISCUSSION
Epigenomic reprogramming has been linked to tissue-specific macrophage phenotypes [18] [19] [20] [21] [22] [23] 38, 39 , but how reprogramming affects inflammatory responses is not well understood 15, [40] [41] [42] . In this study, we found that TNF and IFN-α reprogrammed the human macrophage epigenome to alter inflammatory responses to TLR4 stimulation. TNF induced a balanced response that limited potentially toxic induction of NF-κB target genes encoding inflammatory molecules while enabling expression of genes encoding antiviral and metabolic molecules and Jak-STAT target genes. Type I interferons potentiated the inflammatory function of TNF by preventing the silencing of genes encoding inflammatory molecules. Mechanistically, type I interferons and TNF acted cooperatively to induce signals and TFs that primed chromatin at the promoters of genes encoding inflammatory molecules to make them responsive to weak signals and also resistant to suppression by IL-10. Overall, our findings have identified a previously unknown function for type I interferons and have revealed that signaling crosstalk between IFN-α and TNF is integrated at the level of chromatin to cross-regulate transcriptional responses to LPS.
There are important differences between such TNF-induced reprogramming and the previously described 'endotoxin tolerance' . These include the abolition of TNF-induced silencing of T genes by type I interferons and the nature of the 'NT' response, which determines the functional phenotype of macrophages. The ability of an endogenous cytokine such as IFN-α to prevent the silencing of T genes would suggest that such 'tolerization' is a physiological process that is regulated by cytokines to 'fine tune' the magnitude, duration and qualitative nature of inflammatory responses, rather than being a 'lastditch effort' to prevent the endotoxin toxicity that can lead to profound immunosuppression and death. On the other hand, increased expression of type I interferons, which occurs in several autoimmune diseases, inactivates an important TNF-induced homeostatic mechanism that places a 'brake' on inflammatory gene expression and can contribute to inflammatory pathogenesis.
Our results have provided substantial new insight into the functions and mechanisms that regulate the expression of genes that were effectively or synergistically activated by LPS in TNF-pretreated macrophages (the 'NT response'). One notable finding was discovery of class 3, composed of NT genes encoding molecules important for signaling via the cytokine-Jak-STAT pathway and interferon-antiviral responses. The induction of these genes is functionally important, as it allows cells exposed to TNF-driven inflammation to preserve antiviral host defense. Notably, class 3 genes were tolerized (silenced) in the classical endotoxin tolerance model, as endotoxin induces additional and stronger tolerance mechanisms relative to those induced by TNF 3 . Accordingly, compromised antiviral responses, superinfection and reactivation of latent viruses are major complications in patients with sepsis who have endotoxin-tolerized cells. We have also identified previously unknown classes of 'NT genes' , previously unknown functions for the molecules encoded by NT genes, potential roles for TFs (including SREBP2, AP-1 and E-box proteins), and chromatin-based mechanisms that enable robust induction of NT genes. A primed chromatin state, especially substantial H3K4me3, can greatly reduce the requirements for activation of gene transcription 43 and facilitate robust transcriptional responses to weak signals. The results overall are consistent with a 'sequential rheostat' model in which environmental cues can independently regulate the intensity of upstream signaling and the accessibility of downstream chromatin. In this model, closed chromatin can block a strong signal, whereas open or primed chromatin can amplify a weak signal, in a gene-specific manner.
Type I interferons have pleiotropic immunostimulatory and immunosuppressive effects 6 . Little is known about the mechanisms that determine context-dependent type I interferon functions. Classically, type I interferons promote inflammation and immunity by inducing the transcription of ISGs with binding sites for ISGF3, STAT proteins and/or IRF TFs and encode chemokines and antigen-presenting molecules. In line with our results, published reports have shown that NF-κB-driven genes encoding inflammatory cytokines, such as those that constitute class 1, are not induced and, if anything, are suppressed by type I interferons 6, 8, 9, 44 . In contrast, in the context of co-treatment with TNF, signaling via the interferon receptor IFNAR was coupled to NF-κB target genes, as it prevented tolerization of a large fraction of genes in classes 1 and 2. Thus, in addition to inducing canonical ISGs, type I interferons regulate chromatin at distinct sets of genes encoding inflammatory molecules and possibly other gene sets. That regulatory role probably extends beyond the system used in this study and might contribute to phenomena such as training of the innate immune system 22, 42 and maintenance of basal immunological responsiveness by commensal microbiota, which has been linked to interferons and increased H3K4me3 at the Tnf and Il6 promoters 7, 45 .
Genomic regulatory sequences show less conservation between humans and mice than do coding sequences. One advantage of using a human macrophage experimental system is that it enables direct comparison with pathogenic macrophages obtained from clinical samples. It is encouraging that our results modeled aspects of geneexpression or chromatin-regulation patterns in monocytes and macrophages from patients during sepsis and recovery and people with RA or SLE 37 . SLE is characterized by interferon production and TLR activation in which TNF can be protective (consistent with the tolerization of genes encoding inflammatory molecules). Such similarities support the utility of our system for modeling and delineating mechanisms relevant for disease pathogenesis. Future work should determine whether type I interferons promote the pathogenesis of SLE in part by preventing the tolerization of T genes encoding inflammatory molecules, as has already been suggested 36 . Equally importantly, the mechanisms we have discovered and data sets we have developed provide molecular signatures linked to pathogenic cytokines and pathways that could motivate and help guide the interpretation of studies of samples from patients. Finally, our in vitro model could be exploited to develop and test the efficacy of therapeutic approaches that target epigenetic mechanisms that regulate cytokine production.
In summary, our results have revealed how signaling crosstalk among type I interferons, TNF and TLR4 is integrated at the level of chromatin and have associated those chromatin changes with the reprogramming of gene expression. They highlight the concept that chromatin is not just a target that propagates signaling cascades but instead serves as an integration node that determines transcriptional output. Our findings provide insight into the regulation of inflammatory gene expression that can be used to develop approaches to modulate macrophage activation and cytokine production by targeting chromatin regulators.
